Gentian Diagnostics ASA

OB:GENT Stock Report

Market Cap: NOK 629.2m

Gentian Diagnostics Valuation

Is GENT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GENT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: GENT (NOK40) is trading above our estimate of fair value (NOK37.46)

Significantly Below Fair Value: GENT is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for GENT?

Key metric: As GENT is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for GENT. This is calculated by dividing GENT's market cap by their current revenue.
What is GENT's PS Ratio?
PS Ratio4x
SalesNOK 154.12m
Market CapNOK 629.23m

Price to Sales Ratio vs Peers

How does GENT's PS Ratio compare to its peers?

The above table shows the PS ratio for GENT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average6.2x
OMDA Omda
1.4x6.9%NOK 572.7m
CONTX ContextVision
3.1x2.7%NOK 419.3m
LIFE Lifecare
14.9x14.3%NOK 225.1m
MEDI Medistim
5.4x3.2%NOK 2.9b
GENT Gentian Diagnostics
4x25.7%NOK 616.9m

Price-To-Sales vs Peers: GENT is good value based on its Price-To-Sales Ratio (4x) compared to the peer average (6.2x).

Price to Sales Ratio vs Industry

How does GENT's PS Ratio compare vs other companies in the European Medical Equipment Industry?

32 CompaniesPrice / SalesEstimated GrowthMarket Cap
GENT 4.0xIndustry Avg. 3.4xNo. of Companies32PS03.26.49.612.816+
32 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: GENT is expensive based on its Price-To-Sales Ratio (4x) compared to the European Medical Equipment industry average (3.4x).

Price to Sales Ratio vs Fair Ratio

What is GENT's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GENT PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio4x
Fair PS Ratio6.2x

Price-To-Sales vs Fair Ratio: GENT is good value based on its Price-To-Sales Ratio (4x) compared to the estimated Fair Price-To-Sales Ratio (6.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies